Lifecycle
Expired
stage pending
Spin-off detail
K - NewAmsterdam Pharma Co N.V. -> SpinCo
NAMSW / n/a ยท detected 2026-02-18
Triage
Monitor
MONITOR
Confidence
22%
detection/extraction
Listing
n/a
distribution n/a
Extracted thesis
SpinCo name not confidently identified in filing text. Why-spin rationale sentences not found. 3-year revenue values unavailable. 3-year operating income/EBIT values unavailable. Estimated float % unavailable due to missing parent-retained/share data. Management ownership % unavailable. Capitalization/debt detail not clearly disclosed in parsed text. Tax treatment signal not explicit in parsed text.
Risk flags
Estimated float is unavailable from current filing data.
risk
Source Links
3-Year Financials
Revenue by year
Operating income or ebit by year
Margin by year
Margin trend
Ownership and float
Total shares
Parent retained shares percent
Insider or management shares percent
Restricted or locked up shares
Estimated float percent
Assumption noteFloat estimate unavailable from filing text.
Management incentives
Management ownership percent
Equity comp alignment indicators["Securities registered pursuant to Section 12(b) of the Act:  ", "The Nasdaq Stock Market LLC Securities registered pursuant to Section 12(g) of the Act: None Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.", "Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act."]
Parent to spinoff leadership migration